The prevalence of a hepatin-like effect shown on the thromboelastograph in patients undergoing liver transplantation

Liver Transplantation

Volumn 14, Issue 6, 2008, Pages 855-860

  Agarwal, Seema ^a   Senzolo, Marco ^a   Melikian, Clare ^a   Burroughs, Andrew ^a   Mallett, Susan V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEPARIN LYASE; THROMBIN;

ADULT; ALCOHOL LIVER DISEASE; ANTICOAGULATION; ARTICLE; BILIARY CIRRHOSIS; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; REACTION TIME; REPERFUSION; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; THROMBOELASTOGRAPHY; VIRUS HEPATITIS; AGED; BLOOD CLOTTING TEST; CHEMISTRY; COMPUTER PROGRAM; METABOLISM; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; BLOOD COAGULATION TESTS; HEPARIN; HEPARIN LYASE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MIDDLE AGED; REPERFUSION; RETROSPECTIVE STUDIES; SOFTWARE; THROMBELASTOGRAPHY; THROMBIN; TREATMENT OUTCOME;

EID: 46049118409     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21437     Document Type: Article

References (24)

1. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-896.
2. Kang Y. Coagulation and liver transplantation: current concepts. Liver Transpl Surg 1997;3:465-467.
3. Nielsen V. The detection of changes in heparin activity in the rabbit: a comparison of anti Xa activity, thromboelastography, activated partial thromboplastin time and activated coagulation time. Anesth Analg 2002;95:1503-1506.
4. Coppell J, Thalheimer U, Zambruni A, Triantos C, Riddell A, Burroughs A, Perry D. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the TEG: an in vitro comparison of standard and heparinase modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 2006; 17:97-104.
5. Senzolo M, Coppell J, Cholangitas E, Burroughs A. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007; 18:227-236.
6. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thromboelastography in liver transplantation. Br J Anaesth 1997;78:175-179.
7. Bakker C, Stibbe J, Gomes M, Groenland T, Metselaar H, Hesselink E, et al. The appearance of donor heparin in the recipient after reperfusion of a liver graft. Transplantation 1993;56:327-329.
8. Ketiner S, Gonano C, Seebach F. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998;86:691-695.
9. McKee R, Hodson S, Dawes J, Garden O, Carter D. Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 1992;33:1549-1552.
10. Jakab F, Zavodszky Z, Sugar I, Ughy T. Changes in heparin level in experimental liver transplantation in dog. Acta Chir Hung 1988;29:15-20.
11. Nielsen V, Geary B. Hepatoenteric ischaemia-reperfusion increases circulating heparinoid activity in rabbits. J Crit Care 2000; 15:142-146.
12. Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and noncirrhotic patients. Scand J Gastroenterol 2004;39:830-836.
13. Ben-Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by TEG. J Hepatol 1997;26:554-559.
14. Segal H, Cottam S, Potter D, Hunt B. Coagulation and fibrinolysis in PBC compared with other liver disease and during OLT. Hepatology 1997;25:683-688.
15. Bayly R, Thick M. Reversal of post reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. Br J Anaesth 1994;73:840-842.
16. Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth 2001;48:1075-1079.
17. Hendriks HG, van der MJ, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, et al. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11 (suppl 1):S87-S93.
18. Pivalizza E, Abramson D, King F. Thromboelastography with heparinase in orthotopic liver transplantation. J Cardiothor Vasc Anesth 1998; 12:305-825.
19. Rivard G, Brummel-Ziedins K, Mann K, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haem 2005;3:2039-2043.
20. Chau TN, Chan YW, Patch D, Tokunaga S, Greenslade L, Burroughs AK. Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 1998;43:267-271.
21. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 1990;40: 498-530.
22. Bjornsson TD, Wolfram K. Intersubject intervariability in the anticoagulant response to heparin in vitro. Eur J Clin Pharmacol 1982;21:491-497.
23. Monteagudo J, Reverter JC, Pereira A, Pijoan J, Balust J, Escolar G, et al. Prothrombin fragment 1 + 2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation. Haemostasis 1993;23:51-57.
24. Bouma B, Mosnier L. Thrombin activatable fibrinolysis inhibitor - TAFI - how does thrombin regulate fibrinolysis? Ann Med 2006;38:378-388.